FDA Drug · D-0393-2026

Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-06

Class II · Ongoing

Lack of Assurance of Sterility

Affected lots / codes — check yours against thisLot 240903, exp 9/30/2026

Recalling firm: New Life Pharma LLC, Northvale, NJ
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 2 vials
Distribution: OH
Recall initiated: February 26, 2026
Classified: March 17, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0393-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →